This information is current as Costimulatory Molecules CD 80 and CD 86 NK Cell Triggering by the Human Ljunggren

[1]  F. Farzaneh,et al.  Expression of a variant of CD28 on a subpopulation of human NK cells: implications for B7-mediated stimulation of NK cells. , 1999, Journal of immunology.

[2]  H. Ljunggren,et al.  Triggering of murine NK cells by CD40 and CD86 (B7-2). , 1999, Journal of immunology.

[3]  P. Ricciardi-Castagnoli,et al.  Dendritic cells directly trigger NK cell functions: Cross-talk relevant in innate anti-tumor immune responses in vivo , 1999, Nature Medicine.

[4]  R. Biassoni,et al.  NKp44, A Triggering Receptor Involved in Tumor Cell Lysis by Activated Human Natural Killer Cells, Is a Novel Member of the Immunoglobulin Superfamily , 1999, The Journal of experimental medicine.

[5]  W. Seaman,et al.  Mouse Ly-49D Recognizes H-2Dd and Activates Natural Killer Cell Cytotoxicity , 1999, The Journal of experimental medicine.

[6]  H. Ljunggren,et al.  The Qa‐1b molecule binds to a large subpopulation of murine NK cells , 1998, European journal of immunology.

[7]  J. Altman,et al.  Mouse CD94/NKG2A Is a Natural Killer Cell Receptor for the Nonclassical Major Histocompatibility Complex (MHC) Class I Molecule Qa-1b , 1998, The Journal of experimental medicine.

[8]  R. Biassoni,et al.  Molecular Cloning of NKp46: A Novel Member of the Immunoglobulin Superfamily Involved in Triggering of Natural Cytotoxicity , 1998, The Journal of experimental medicine.

[9]  Jun Wu,et al.  Association of DAP12 with activating CD94/NKG2C NK cell receptors. , 1998, Immunity.

[10]  M. Llano,et al.  HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[11]  B. Wollenberg,et al.  Absence of B7.1‐CD28/CTLA‐4‐mediated co‐stimulation in human NK cells , 1998, European journal of immunology.

[12]  J. Bell,et al.  HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C , 1998, Nature.

[13]  L. Moretta,et al.  p46, a Novel Natural Killer Cell–specific Surface Molecule That Mediates Cell Activation , 1997, The Journal of experimental medicine.

[14]  L. Moretta,et al.  HLA class I specific inhibitory receptors. , 1997, Current opinion in immunology.

[15]  H. Spits,et al.  A New Mechanism of NK Cell Cytotoxicity Activation: The CD40–CD40 Ligand Interaction , 1997, The Journal of experimental medicine.

[16]  S. Anderson,et al.  Selective inhibition of human and mouse natural killer tumor recognition using retroviral antisense in primary natural killer cells: involvement with MHC class I killer cell inhibitory receptors. , 1997, Journal of immunology.

[17]  L. Lanier,et al.  Arousal and inhibition of human NK cells , 1997, Immunological reviews.

[18]  D. Mager,et al.  The Ly‐49 family: genes, proteins and recognition of class I MHC , 1997, Immunological reviews.

[19]  H. Ljunggren,et al.  Triggering of natural killer cells by the costimulatory molecule CD80 (B7-1) , 1996, Immunity.

[20]  R. Schmidt,et al.  Impaired IgG-Dependent Anaphylaxis and Arthus Reaction in FcγRIII (CD16) Deficient Mice , 1996 .

[21]  D. Raulet.  Recognition events that inhibit and activate natural killer cells. , 1996, Current opinion in immunology.

[22]  C. Benoist,et al.  Independent Modes of Natural Killing Distinguished in Mice Lacking Lag3 , 1996, Science.

[23]  J. Bertoglio,et al.  CD28-mediated cytotoxicity of YT natural killer cells on B7-positive targets induces rapid necrotic death independent of granule exocytosis. , 1996, Cellular Immunology.

[24]  R. Biassoni,et al.  The human leukocyte antigen (HLA)-C-specific "activatory" or "inhibitory" natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions , 1996, The Journal of experimental medicine.

[25]  E. Jaffee,et al.  A reassessment of the role of B7-1 expression in tumor rejection , 1995, The Journal of experimental medicine.

[26]  L. Moretta,et al.  Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells , 1995, The Journal of experimental medicine.

[27]  P. De Baetselier,et al.  Expression of B7-1 by highly metastatic mouse T lymphomas induces optimal natural killer cell-mediated cytotoxicity. , 1995, Cancer research.

[28]  G. Forni,et al.  Co‐expression of B7‐1 and ICAM‐1 on tumors is required for rejection and the establishment of a memory response , 1995, European journal of immunology.

[29]  J. Allison,et al.  CD28-mediated costimulation is necessary for optimal proliferation of murine NK cells. , 1994, Journal of immunology.

[30]  J. Ravetch,et al.  FcR γ chain deletion results in pleiotrophic effector cell defects , 1994, Cell.

[31]  M. Bennett,et al.  Cloning and characterization of the 2B4 gene encoding a molecule associated with non-MHC-restricted killing mediated by activated natural killer cells and T cells. , 1993, Journal of immunology.

[32]  J. Ritz,et al.  Costimulatory signals are required for optimal proliferation of human natural killer cells. , 1993, Journal of immunology.

[33]  L. Lanier,et al.  Involvement of CD28 in MHC-unrestricted cytotoxicity mediated by a human natural killer leukemia cell line. , 1992, Journal of immunology.

[34]  W. Yokoyama,et al.  Stimulation of murine natural killer (NK) cells by a monoclonal antibody specific for the NK1.1 antigen. IL-2-activated NK cells possess additional specific stimulation pathways. , 1991, Journal of immunology.

[35]  W. Seaman,et al.  Molecular cloning of gp42, a cell-surface molecule that is selectively induced on rat natural killer cells by interleukin 2: glycolipid membrane anchoring and capacity for transmembrane signaling , 1991, The Journal of experimental medicine.

[36]  A. Deleo,et al.  Monoclonal antibody to a triggering structure expressed on rat natural killer cells and adherent lymphokine-activated killer cells , 1989, The Journal of experimental medicine.

[37]  J. C. Pratt,et al.  Activation of cytolytic T lymphocyte and natural killer cell function through the T11 sheep erythrocyte binding protein , 1985, Nature.

[38]  Andreas Hutloff,et al.  ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28 , 1999, Nature.

[39]  H. Ljunggren,et al.  Triggering of natural killer cell mediated cytotoxicity by costimulatory molecules. , 1998, Current topics in microbiology and immunology.

[40]  L. Lanier.  NK cell receptors. , 1998, Annual review of immunology.

[41]  P. De Baetselier,et al.  Interleukin-12-activated natural killer cells recognize B7 costimulatory molecules on tumor cells and autologous dendritic cells. , 1998, Blood.

[42]  M. Llano,et al.  The CD94/NKG2 C-type lectin receptor complex , 1998, Current topics in microbiology and immunology.

[43]  S. Park,et al.  Mouse CD1-specific NK1 T cells: development, specificity, and function. , 1997, Annual review of immunology.

[44]  Z. Brahmi,et al.  Upregulation of B7 molecules by the Epstein-Barr virus enhances susceptibility to lysis by a human NK-like cell line. , 1995, Cellular immunology.

[45]  H. Ljunggren,et al.  In search of the 'missing self': MHC molecules and NK cell recognition. , 1990, Immunology today.

[46]  G. Trinchieri,et al.  Preferential proliferation of natural killer cells among peripheral blood mononuclear cells cocultured with B lymphoblastoid cell lines. , 1987, Natural immunity and cell growth regulation.